22-21387646-A-C
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_ModerateBA1
The NM_001128635.2(RIMBP3B):āc.3788A>Cā(p.Glu1263Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 13/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.25 ( 0 hom., cov: 0)
Exomes š: 0.17 ( 1248 hom. )
Failed GnomAD Quality Control
Consequence
RIMBP3B
NM_001128635.2 missense
NM_001128635.2 missense
Scores
16
Clinical Significance
Conservation
PhyloP100: 1.92
Genes affected
RIMBP3B (HGNC:33891): (RIMS binding protein 3B) Predicted to enable benzodiazepine receptor binding activity. Predicted to be involved in fertilization and spermatid development. Predicted to be located in cytoplasm. Predicted to be active in nucleus. Predicted to colocalize with manchette. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.10921261).
BA1
GnomAdExome4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.334 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RIMBP3B | NM_001128635.2 | c.3788A>C | p.Glu1263Ala | missense_variant | 1/1 | ENST00000620804.2 | NP_001122107.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RIMBP3B | ENST00000620804.2 | c.3788A>C | p.Glu1263Ala | missense_variant | 1/1 | NM_001128635.2 | ENSP00000479326 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 0AN: 2Hom.: 0 Cov.: 0 FAILED QC
GnomAD3 genomes
AF:
AC:
0
AN:
2
Hom.:
Cov.:
0
FAILED QC
Gnomad EAS
AF:
GnomAD4 exome AF: 0.165 AC: 14386AN: 87098Hom.: 1248 Cov.: 0 AF XY: 0.164 AC XY: 8209AN XY: 50050
GnomAD4 exome
AF:
AC:
14386
AN:
87098
Hom.:
Cov.:
0
AF XY:
AC XY:
8209
AN XY:
50050
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.250 AC: 1AN: 4Hom.: 0 Cov.: 0 AF XY: 0.500 AC XY: 1AN XY: 2
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
1
AN:
4
Hom.:
Cov.:
0
AF XY:
AC XY:
1
AN XY:
2
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 31, 2022 | The c.3788A>C (p.E1263A) alteration is located in exon 1 (coding exon 1) of the RIMBP3B gene. This alteration results from a A to C substitution at nucleotide position 3788, causing the glutamic acid (E) at amino acid position 1263 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T
M_CAP
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
L
MutationTaster
Benign
P;P
PrimateAI
Benign
T
Sift4G
Benign
T
Vest4
MVP
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at